Form4insider filings, from the source

SEC Form 4 · accession 0001193125-26-395847

Oscar Health, Inc. · OSCR

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Claremount TW, L.P.
Director · 10% Owner
Claremount VII Associates, L.P.
Director · 10% Owner
Thrive Partners III GP, LLC
Director · 10% Owner
Thrive Partners II GP, LLC
Director · 10% Owner
Thrive Partners VII GP, LLC
Director · 10% Owner
Period of report
Sep 18, 2026
Accepted (ET)
Sep 18, 2026 · 8:21 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001568651

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Class A Common StockF1,F2,F3Sep 18, 2026J6,268,097$0.00D0IBy Thrive Capital Partners VII Growth, L.P.
Class A Common StockF1,F2,F3Sep 18, 2026J75,520$0.00D0IBy Claremount VII Associates, L.P.
Class A Common StockF1,F2,F3Sep 18, 2026J1,323,589$0.00A1,323,589IBy Thrive Capital Partners II, L.P.
Class A Common StockF1,F2,F3Sep 18, 2026J4,855,810$0.00A4,855,810IBy Thrive Capital Partners III, L.P.
Class A Common StockF1,F2,F3Sep 18, 2026J164,218$0.00A164,218IBy Claremount TW, L.P.
Class A Common StockF4,F2,F3Sep 18, 2026J1,323,589$0.00D0IBy Thrive Capital Partners II, L.P.
Class A Common StockF4,F2,F3Sep 18, 2026J4,855,810$0.00D0IBy Thrive Capital Partners III, L.P.
Class A Common StockF4,F2,F3Sep 18, 2026J164,218$0.00D0IBy Claremount TW, L.P.

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Class B Common StockF1,F2,F3,F5—Sep 18, 2026J1,323,589D——Class A Common Stock1,323,5894,779,730I
Class B Common StockF1,F2,F3,F5—Sep 18, 2026J4,855,810D——Class A Common Stock4,855,81017,535,258I
Class B Common StockF1,F2,F3,F5—Sep 18, 2026J164,218D——Class A Common Stock164,218593,021I
Class B Common StockF1,F2,F3,F5—Sep 18, 2026J6,268,097A——Class A Common Stock6,268,0976,268,097I
Class B Common StockF1,F2,F3,F5—Sep 18, 2026J75,520A——Class A Common Stock75,52075,520I
Class B Common StockF2,F3,F5—holding—————Class A Common Stock1,040,7041,040,704I
Class B Common StockF2,F3,F5—holding—————Class A Common Stock19,23919,239I
Class B Common StockF2,F3,F5—holding—————Class A Common Stock2,498,5132,498,513I
Class B Common StockF2,F3,F5—holding—————Class A Common Stock48,98248,982I

Explanation of responses

Remarks

Joshua Kushner has been deputized to represent the Reporting Persons on the board of directors of the Issuer. By virtue of Mr. Kushner's representation, for purposes of Section 16 of the Exchange Act, each of the Reporting Persons may be deemed directors by deputization of the Issuer. Mr. Kushner has filed a separate Section 16 report disclosing securities of the Issuer that he may be deemed to beneficially own for Section 16 purposes.